By Alex Philippidis

NEW YORK (GenomeWeb News) – The Ontario Institute for Cancer Research will expand efforts to translate its research over the next five years, in part through a greater focus on personalized medicine and building partnerships with industry and other research institutions, according to its Strategic Plan 2010-2015 recently made public on the institute's website.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: swapping yeast genes with human orthologs to study conservation of function, and more.

Hong Kong is using DNA phenotyping to shame litterers.

A study appearing in Cell suggests some metastatic castration-resistant prostate cancer patients could benefit from PARP inhibitor therapy.

NIH's Francis Collins writes that scientific advances are poised to help populations all over the world, but more scientists are needed to keep the momentum.